GBT 外汇新闻

Drug major Pfizer Inc. (PFE) and biopharmaceutical company Global Blood Therapeutics, Inc. (GBT) announced Monday the companies have entered into a definitive agreement under which Pfizer will acquire GBT in an all-cash deal valued at $5.4 billion.